Patents by Inventor Sang Woong Kim

Sang Woong Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINAZOLINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES AND OBESITY
    Publication number: 20080207614
    Abstract: The present invention relates to novel quinazoline derivatives effective in lowering blood glucose level and body weight, and a medicine for treatment and/or prevention of diabetes and/or obesity, which comprises the compound as an active ingredient.
    Type: Application
    Filed: June 29, 2007
    Publication date: August 28, 2008
    Applicants: SK CHEMICALS CO., LTD., LEADGENEX INC., INDUSTRY ACADEMIC COOPERATION FOUNDATION OF KYUNGHEE UNIVERSITY
    Inventors: Nam Kyu Lee, Jun Won Lee, Sukho Lee, Guang-Jin Im, Hye Young Han, Tae Kon Kim, Yong Hyuk Kim, Wie-Jong Kwak, Sang Woong Kim, Joohun Ha, Eon Kyum Kim, Jung Kyu Lee, Choong Yeul Yoo, Dae Yeon Lee
  • CDK inhibitors having flavone structure
    Patent number: 6500846
    Abstract: The present invention relates to a novel flavone derivative, pharmaceutically acceptable salt, hydrate, solvate and isomer thereof which is useful as an inhibitor against Cyclin Dependent Kinase (CDK), a process for preparation thereof, and a composition of anti-cancer agent or agent for treating neurodegenerative disease comprising this compound as an active ingredient.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: December 31, 2002
    Assignee: LG Chemical, Ltd.
    Inventors: Chang Yong Hong, Tae Sik Park, Young Kwan Kim, Jin Ho Lee, Jong Hyun Kim, Dong Myung Kim, Ho Sun Son, Sang Woong Kim, Eunice Eun Kyeong Kim
  • Hydantoin compounds and methods related thereto
    Patent number: 6384061
    Abstract: The present invention relates to novel hydantoin compounds represented by formula (I) which shows an inhibitory activity against farnesyl transferase, and thus can be used as an anti-cancer agent, or pharmaceutically acceptable salts thereof, in which R1, R2, R3 and R4 are as defined in the present application. The present invention also relates to a process for preparation of the compound of formula (I), and to an anti-cancer composition comprising the compound of formula (I) as an active ingredient.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: May 7, 2002
    Assignee: LG Chemical Ltd.
    Inventors: Jin Ho Lee, Jong Sung Koh, Jong Hyun Kim, Hyun Il Lee, Won Hee Jung, Seong Gu Ro, You Seong Shin, Sang Woong Kim, Ki Won Park, Tae Hwan Kwak, Kyung Duk Moon, Hyun Ho Chung